Tech Company Financing Transactions
Glycos Biotechnologies Funding Round
Glycos Biotechnologies, based in Houston, secured $5 million from Threshold Ventures and Mercury Fund.
Transaction Overview
Company Name
Announced On
4/17/2009
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Threshold Ventures (Lead Investor) (Steven Jurvetson)
Mercury Fund (Daniel Watkins)
Proceeds Purpose
Proceeds from the Series A financing will be used to hire key technical talent and to commercialize GlycosBio technology to manufacturing scale.
Company Information
Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
2450 Holcombe Blvd. J-510
Houston, TX 77021
USA
Houston, TX 77021
USA
Phone
Website
Email Address
Overview
Glycos Biotechnologies is an International biochemical company commercializing sustainable chemicals made from renewable feedstocks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Cilento
Chief Financial Officer
Walter Burnap
Chief Scientific Officer
Paul Campbell
VP - Finance
Kevin Mitchell
VP - R & D
Daniel Monticello
Browse more venture capital transactions:
Prev: 4/17/2009: Calient Technologies venture capital transaction
Next: 4/17/2009: Naverus venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs